GlassScriptPhysician profile
Nicholas Stockwell
NPI 1225411242
$20,424.65
in general payments reported to CMS, 2019-2025
13 companies · $2,361 in 2025
The $2,361 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $5,134 · 2021: $12K · 2022: $150 · 2023: $128 · 2024: $110 · 2025: $2,361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,370 · Travel and Lodging: $1,209 · Entertainment: $19.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,369.98 |
| Travel and Lodging | $1,209.41 |
| Entertainment | $19.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11,168.24 | 2020-2022 | |
| Arthrex, INC. | $5,894.34 | 2021-2025 | |
| Legacy Ortho LLC | $1,200.00 | 2021 | |
| Exactech, INC. | $847.07 | 2021 | |
| Gemini Mountain Medical, LLC | $531.42 | 2023-2025 | |
| Stryker Corporation | $222.20 | 2019-2025 | Gamma, Mako |
| Xiros INC | $196.37 | 2021 | |
| Depuy Synthes Sales INC. | $158.70 | 2019-2023 | Monovisc, Orthovisc, Healix Knotless Peek |
| Medical Device Business Services, INC. | $135.98 | 2019 | |
| Abbott Laboratories | $20.39 | 2024 | Eterna |
| Argentum Medical | $19.70 | 2024 | |
| Vericel Corporation | $16.33 | 2023 | Maci |
| Boston Scientific Corporation | $13.91 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Stockwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.